Our board moves wrap includes Benjamin Donovan, Graeme Morissey, Simon Robertson, John Traicos, Anson Heng, Chris Ntoumenopoulos, Paul Rennie, Tony Keating, and Stephen Quantrill.
Pfizer takeover target ResApp has had its valuation cut after its COVID-19 detecting cough tool failed to meet performance requirements needed to lock in an improved all-cash offer for the business.
Pfizer has made a $100 million bid for WA-founded med-tech company ResApp Health, as it announces a six-month research partnership for COVID-19 products.
Shares in digital health company ResApp Health have closed up 33 per cent today to 20 cents, after it received European regulatory approval for its first commercial product – the ResAppDx-EU.
Shares in medical tech firm ResApp Health have more than halved today, after the company released the preliminary results of a new US study on its technology.
Medical tech company ResApp Health has announced a $7.5 million capital raising as it moves to commercialise its smartphone app, which aims to diagnose and manage respiratory diseases.
Shares in medical tech company ResApp Health slumped today after it released positive test results, following a spike in the share price leading up to the announcement.
Norwood Systems and ResApp Health are small tech companies with global potential and, judging by their share price gains this month, investors have latched on to the latter.
Shares in recently listed companies Norwood Systems and ResApp Health have surged in recent weeks as investors warm to the wave of tech companies completing reverse takeovers.
Digital medicine developer ResApp Health has announced its second clinical trial program in Perth as it seeks to accelerate the testing of its smartphone-based diagnosis of respiratory disease.
Perth-based biotech company ResApp Health had a steady first day of trade on the ASX today, after being acquired by Narhex Life Sciences in an $11 million backdoor listing.
